Letter to the editor regarding the article: "Lacrimal gland botulinum toxin injection for epiphora management"

Orbit. 2023 Aug;42(4):468-469. doi: 10.1080/01676830.2022.2126502. Epub 2022 Sep 20.

Authors

Collin Anderson¹, Robert T Swan¹, Robert Hill^{1

2}

Affiliations

¹ Department of Ophthalmology and Visual Sciences, SUNY Upstate Medical University, Syracuse, New York, USA.
² Eye Plastics and Reconstructive Surgeons, North Syracuse, New York, USA.

PMID: 36124825
DOI: 10.1080/01676830.2022.2126502

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Botulinum Toxins* / therapeutic use
Botulinum Toxins, Type A* / therapeutic use
Humans
Lacrimal Apparatus Diseases* / drug therapy
Lacrimal Apparatus*
Lacrimal Duct Obstruction*

Substances

Botulinum Toxins
Botulinum Toxins, Type A